Vixtimotamab

Product Description: Vixtimotamab (AMV-564; TandAb T564) is a bispecific tetravalent tandem diabody (TandAb) that targets human CD33 and human CD3 antigens. Vixtimotamab can be used for the research of acute myeloid leukemia (AML)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Reusch U, et al. Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia. Clin Cancer Res. 2016 Dec 1;22(23):5829-5838.

Molecular Weight: N/A

Compound Purity: 97.29

Research Area: Cancer

Solubility: H2O

Target: Others

• SKU: MEXHY-P99958-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99958-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated